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Monitoring Lys-tRNALys phosphatidylglycerol transferase activity
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Abstract
In some bacteria Lys-tRNALys is used both in translation and for the specific addition of Lys to
phosphatidylglycerol in the cytoplasmic membrane. This reaction is catalyzed by the membrane
protein MprF, and the lysyl-phosphatidylglycerol formed contributes to the resistance of these
bacteria to various cationic antibacterial molecules. Obtaining proteins and reconstituting an in
vitro system mimicking membrane conditions is a major challenge to studying the function of
membrane proteins, especially when labile substrates such as Lys-tRNALys are required. Here we
report methods to obtain a stable enriched membrane fraction containing MprF, and the techniques
necessary to quantitatively monitor its activity in vitro and in vivo.
1. Introduction
One of the major mechanisms by which bacteria adapt to variations in the physicochemical
conditions of their habitat takes place at the level of the cellular envelope that modulates the
flow of ions, nutrients, proteins, and antibiotics into and out of the cell. Reduction of the net
negative charge of the cell envelope is a strategy used by numerous bacteria to decrease their
affinity for cationic antimicrobial molecules. This change in charge is accomplished by the
transfer of positively charged groups to the negatively charged constituents of the cell envelope
(1). Teichoic acid in the cell wall of Gram-positive bacteria, lipopolysaccharide in the outer
membrane of Gram-negative bacteria and phospholipids in bacterial cytoplasmic membranes,
together determine the net negative charge of the bacterial envelope. A decrease in the net
negative charge of these components can be achieved through four different pathways: i)
attachment of D-Ala to teichoic acid (2), ii) acylation of the lipopolysaccharide with positively
charged molecules (i.e. modification of lipid A with 4-amino-4-deoxy-L-arabinose), iii)
biosynthesis of phosphatidylethanolamine (PE) (3) and iv) lysylation of phosphatidylglycerol
(PG) (4). PG lysylation activity, first discovered in Staphylococcus aureus (5), involves transfer
of a Lys moiety from the 3’-end of tRNALys to the free distal hydroxyl group of the glycerol
moiety of PG (6,7). The specificity of the staphylococcal protein was investigated, showing
that the Lys analog S-(2-aminoethyl)-l-cysteine can be efficiently processed when attached to
E. coli tRNALys but not tRNACys (7). However, the biological significance of PG lysinylation
was still not understood. The protein MprF (Multipeptide resistance factor) was recently
identified as an integral membrane protein responsible for this transferase activity and was
recognized as a novel virulence factor in certain pathogenic organisms. In S. aureus MprF
confers resistance to diverse pore forming cationic peptides produced by the immune system
such as defensins secreted by neutrophils and protegrins produced by leukocytes. A
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staphylococal mprF deletion strain exhibited an attenuated resistance to human neutrophiles
killing and a reduced virulence in mice (4). In addition MprF confers resistance to lanthionine-
containing peptides (lantibiotics) secreted by certain bacteria such as nisin produced by
Lactococcus lactis (4) and also to several other positively charged antibiotics
(aminoglycosides, betalactamines and glycopeptides)(8,9). The MprF pathway plays a role in
the virulence of Listeria monocytogenes and may also provide a selective advantage to non-
pathogenic organisms during colonization of their natural habitats (10).
While the physiological significance of the MprF pathway has recently been explored, and
qualitative in vitro TLC assays were set up using radiolabeled Lys (11), there is to date no
convenient in vitro assay to quantitatively monitor the Lys-tRNALys PG transferase activity.
Here we report general methods to express and obtain an enriched cellular fraction containing
active MprF. A quantitative in vitro assay was established to monitor Lys-tRNALys PG
transferase activity, and this method was applied to optimize detergent and substrate
concentrations for future studies.
2. Expression of MprF in Escherichia coli, preparation of membrane fractions,
and analysis of lipids by TLC
2.1 Cloning of MprF from Bacillus subtilis and its expression in E. coli
MprF is not naturally expressed in E. coli, providing an ideal system for heterologous
production of the protein. The ORF yfiW-yfiX from B. subtilis (a sequencing error led to
misannotation of the gene as split into two ORFs) was amplified by PCR (primers: fwd, 5′-
ctgcagtctagaagcttagacggagtcttttttgctt-3′, rev, 5′-ccatggaattcggatccatgctgattaaaaagaatgctttat-3′)
and cloned under the control of the T7 promoter at the BamHI/HindIII sites of the vector pet33b
(kanR, Novagen). Expression of the protein was attempted in three strains derived from E.
coli BL21 DE3; Rosetta2 DE3 (Novagen), and strains C41 and C43 which both contain the
plasmid pRARE2 (CamR, Novagen) encoding tRNAs for translation of rare codons. Strains
C41 and C43 are widely used to express toxic or membrane proteins and generally give better
results than the conventional BL21 strain (12).
Overproduction of B. subtilis MprF was performed in an autodinduction medium or in LB with
induction of expression by addition of 1 mM IPTG at OD600nm = 0.6. One liter of autoinduction
medium was reconstituted with independently sterilized solutions by mixing 930 ml LB
without salt, 1 ml 1 M MgSO4, 1ml filtered sterilized trace metal solution (50 μM FeCl3, 20
μM CaCl2, 10 μM MnCl2 and ZnCl2, 2 μM CoCl2, CuCl2, NiCl2, MoSO4, SeCl2 and
H3BO3), 20 ml carbon source solution containing 25% glycerol, 2.5% Glucose and 10% lactose
(w/v) and 50 ml of a buffer containing 1 M KH2PO4, 1 M Na2HPO4 and 0.5 M (NH4)2SO4.
Both media contained 25 mg/l chloramphenicol and 50 mg/l kanamycin and were inoculated
at 1/100 of the final media volume with a starter culture, and then cultured at 37 °C overnight
under vigorous shaking. Cells were harvested by centrifugation and were frozen at −80 °C.
Expression levels of MprF were assessed by measuring the specific activity of Lys-tRNALys
PG transferase in crude extracts (section 3.1 below). The highest yields of active MprF were
obtained by using the strain C41 DE3 grown in autoinduction medium.
2.2 Membrane fraction preparation
Membrane fractions were prepared by differential centrifugation and all the following steps
were performed at 4 °C. To prepare crude cell extracts, 1.6 g of frozen cell paste were sonicated
8 times 30 s in 5 ml of buffer A (50 mM Tris-HCl pH 8.0, 1 mM DIFP, 1 mM PMSF and 3
mM β-mercaptoethanol) with a 3 mm probe mounted on a Branson sonifier 450. Cellular debris
were sedimented by centrifugation for 10 min at 10,000 × g. The debris pellet was re-extracted
twice with 5 ml of buffer A and all the supernatants were pooled together. During this step,
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62% of the total activity was lost (Table 1). However, all the activity of the 10,000 × g
supernatant containing the cellular membranes was recovered by ultracentrifugation at 250,000
× g for 45 min. The membrane pellet was then washed 3 times with 4 ml of buffer A before
dispersion in 1.5 ml of buffer A by brief sonication on the “low” power setting (Branson
Sonifier 450). The MprF activity of this fraction was enriched 2.3-fold (Table 1) and remained
stable at −80 °C for several months upon addition of 0.6 ml of buffer A containing 70 %
glycerol. Analysis by SDS page of the membrane fraction revealed a weak band at 100 kDa
and an intense band at 50 kDa indicating proteolytic degradation of the full length protein.
2.3 Preparation of total lipids
Biosynthesis of lysylated-PG (Lys-PG) in wild-type B. subtilis or in E. coli strains producing
MprF can be monitored by analyzing their lipid composition by TLC. For this purpose, total
lipids were extracted from 15 − 30 OD of harvested cells using the Bligh and Dyer extraction
method (13) modified as follows. The cell pellet was resuspended in 0.2 ml of 120 mM sodium
acetate pH 4.5 by vortexing. Low pH stabilizes the ester linkage of Lys to PG and enhances
the extraction yield of polar lipids. A sonication step can be added to increase the yield of
extraction when lipids are prepared from B. subtilis. To 0.2 ml of the resuspended cells, 0.75
ml chloroform:methanol (1:2, v:v) were added and the lipids were extracted by vortexing the
mix for 10 min at room temperature. 0.25 ml of chloroform and 0.25 ml of 120 mM sodium
acetate pH 4.5 were successively added and mixed by vortexing. The organic and aqueous
phases were separated by centrifugation and the organic (lower) phase containing the lipids
was collected and dried under vacuum. The dried lipids were finally resuspended in 50 μl of
chloroform:methanol (2:1, v:v).
Phospholipids are the main lipids of bacterial membranes and their formation and relative
abundance can be determined by in vivo radioactive labelling, and their relative composition
analyzed by TLC. The protocol above can be scaled up for preparation of lipids from litres of
media or scaled down for in vivo [32P] labelling of phospholipids (Fig. 1). In the latter case, 2
ml of media supplemented with 2 × 106 cpm of [32P]PPi (PerkinElmer) were inoculated with
20 μl of an overnight pre-culture, all solvent volumes necessary for the lipid extraction were
decreased two-fold and the sonication step omitted.
2.4 TLC analysis of lipids
5 − 10 μl of the unlabeled lipid preparation or a suitable amount of radiolabeled [32P]
phospholipids were spotted on a 10 cm long 250 μ HLF silicagel TLC plate (Analtech). The
TLC was developed in one or two dimensions using successively the solvents
chloroform:methanol:water (14:6:1, v:v:v) in the first dimension and
chloroform:methanol:acetic acid (13:5:2, v:v:v) in the second dimension (Fig. 1). Each
dimension ran for 20 min; a longer migration time resulted in compression of the migrating
lipids at the solvent front. Unsaturated fatty acid chains (57% of the total E. coli fatty acid
chains) were visualized by exposure of the dried TLC to iodine vapors. Detection of amino
groups was performed with ninhydrin, and of phosphate groups by using molybdenum blue
(Sigma) (14). Radiolabeled phospholipids were revealed by phosphorimaging (Fig. 1).
3. n vitro assays of Lys-tRNALys phosphatidylglycerol transferase activity
In our in vitro assay, Lys-tRNALys is steadily provided to MprF by an excess of E. coli lysyl-
tRNA synthetase (LysRS) in the presence of tRNALys, free [14C]Lys, ATP and PG according
to the following scheme:
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PG is not soluble in water and forms liposomes upon sonication or vortexing. Since MprF was
isolated in a membrane fraction and the amount of embedded PG was not sufficient to promote
the saturation of MprF, PG liposomes were added to the reaction media as substrates for the
reaction. However, without addition of exogenous PG and in the presence of larger amounts
of membrane extract, a very weak MprF activity (0.02 pmol/min/μg) can be measured that
results from the lysinylation of PG present in the membrane extract. The length of pre-
incubation necessary to allow fusion of cellular membranes with PG liposomes, as well as the
concentration of PG, were both critical in establishing a reproducible in vitro assay. The use
of detergent (Triton X100) was also helpful for the efficient reconstitution of numerous
membrane activities and was investigated in more detail (section 3.4 below).
3.1 Steady-state assays for Lys-tRNALys PG transferase activity
PG liposomes were prepared by resuspending dried egg yolk PG (Sigma P0514) in buffer B
containing 100 mM Hepes-NaOH pH 7.2, 10 mM MgCl2, 30 mM KCl and then vortexing for
15 min at room temperature. Total tRNA from E. coli was used as substrate and was prepared
from an E. coli strain overexpressing tRNALys (15). 20% of the total tRNA from this strain
could be aminoacylated with [14C]Lys as determined from aminoacylation plateau levels.
LysRS and stock solutions of membrane fractions were diluted with buffer B. Reconstitution
of the reaction medium was performed by the sequential addition of 1) the liposome solution,
2) water, 3) detergent (Triton X-100) and 4) the membrane fraction. The mix was pre-incubated
at 37 °C (section 3.2) and the Lys-tRNALys PG transferase reaction was started by addition of
an aminoacylation mix containing ATP, Lys-tRNALys, LysRS, buffer and salt (see
concentrations below). The aminoacylation mix was pre-incubated for 5 min at 37 °C to pre-
form Lys-tRNALys. Initiation of the reaction by addition of the membrane fraction or short
pre-incubation times of the membrane fraction with PG resulted in biphasic kinetics. Once
reconstituted, the Lys-tRNALys PG transferase reaction media contained 100 mM Hepes-
NaOH pH 7.2, 10 mM MgCl2, 30 mM KCl, 8 mM ATP, 14 μM [14C]Lys (230 cpm/pmol), 2
mg/ml PG liposomes, 1.76 mg/ml Triton X-100, 5 μM tRNALys, 0.2 μM affinity tag purified
E. coli LysRS (16) and 0.4 mg/ml of the membrane protein fraction with or without B.
subtilis MprF (section 2.3). It is worth noting that the amount of LysRS used (0.2 μM, kcat =
108 min−1) ensures that the rate of Lys-tRNALys synthesis (21 μM min−1) is not the limiting
step of the overall reaction scheme since the rate of formation of Lys-PG in all subsequent
experiments never exceeded 2 μM min−1. Two techniques were employed to monitor the
kinetics of Lys-PG synthesis, a TLC procedure to determine the relative amount of Lys-PG
compared to the total amount of Lys, and an extraction procedure that in combination with
standard scintillation methods determines simultaneously the amounts of Lys-tRNALys and
Lys-PG (Fig. 2). Aliquots were periodically removed from the reaction media between 2 − 32
min after initiation. For TLC analysis, aliquots of 1.5 μl were added to 5.6 μl of
chloroform:methanol (1:2, v:v) and the resulting mixtures spotted on silicagel plates and
developed as described in section 2.4. [14C]Lys and derivatives were visualized by
phosphorimaging. Free [14C]Lys and [14C]Lys-tRNALys remained at the TLC origin whereas
[14C]Lys-PG migrated with an Rf = 0.28. The concentration of [14C]Lys-PG in the reaction
was derived from quantification of the ratio of [14C]Lys-PG:(free [14C]Lys+ [14C]Lys-
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tRNALys) multiplied by the initial [14C]Lys concentration (14 μM) (Fig. 2A). The simultaneous
measurement of [14C]Lys-PG formation and the level of aminoacylation of tRNALys was
performed by the quantification of [14C]Lys-tRNALys and [14C]Lys-PG after their
simultaneous extraction from each time course as follows. 8 μl of the reaction media were
added to 500 μl chloroform:methanol:120 mM potassium acetate pH 4.5 (1:2:0.8, v:v:v). In
this solvent, [14C]Lys-PG was stable for several hours at room temperature (data not shown).
At the end of the time course, 130 μl of chloroform and 130 μl of 120 mM potassium acetate
pH 4.5 were successively added and mixed by vortexing for 20 s. Phases were then separated
by centrifugation at room temperature and the lower phases containing [14C]Lys-PG
transferred to a scintillation vial, dried in an oven at 50 °C and the radioactivity then determined
by scintillation counting. The level of [14C]Lys-tRNALys in the aqueous phase was determined
by precipitation of the material by adding 25 μl 3 M potassium acetate pH 4.5 and 1 ml ethanol
followed by incubation at −80°C. The pellet obtained after centrifugation was air dried for 30
min at room temperature, resuspended in 50 μl 60 mM potassium acetate pH 4.5 and spotted
on a 3 MM Whatman filter disc. Free [14C]Lys was removed from the filter disc by washing
two times with 5% TCA and radioactivity determined by scintillation counting.
A good correlation was found between the two techniques for monitoring MprF activity (Fig.
2). TLC analysis revealed a spot migrating above [14C]Lys-PG that may correspond to the
[14C]Lys-monoacyl-PG. The slight differences in the level of [14C]Lys-PG formation between
the two techniques may result from the existence of other lysyl- derivatives that are extractable
by the solvent method but that may not migrate during TLC analysis and stay instead at the
origin. The level of Lys-tRNALys is steady for the first 10 min of the reaction allowing
measurement during this time of the initial velocity of Lys-PG formation.
3.2 Optimization of pre-incubation of PG with membrane fractions
Short pre-incubations of PG liposomes with membrane extract prior to initiation of the reaction
resulted in biphasic kinetics for Lys-PG formation, indicating that sufficient time had not been
allowed for the fusion of PG liposomes with cellular extract membranes. Specific activity of
membrane extracts was determined with the assay described above (section 3.1) after
increasing the pre-incubation time of PG liposomes with membrane fractions (Fig. 3). 10 min
pre-incubation before initiation of the reaction (addition of the aminoacylation mix) was
necessary to obtain maximum specific activity. Longer incubation times did not significantly
improve the specific activity of the extracts.
3.3 Optimal concentration of PG
Before investigating the kinetic parameters of MprF for Lys-tRNALys, it was necessary to
determine whether or not MprF in the membrane preparation was saturated with PG. Saturation
of MprF by PG was determined under the conditions described above (section 3.1) in the
presence of 0.25 mg/ml membrane protein fraction, a saturating amount of Lys-tRNALys (10
μM) and a range of concentrations of PG (0.25−6 mg/ml). Figure 4 shows that 2 mg/ml of PG
was sufficient to saturate MprF under these conditions.
3.4 Use of detergent
The use of detergents greatly facilitates in vitro reconstitution of various membrane activities
(for reviews e.g. (17,18)). Mixed lipid liposomes containing detergents constitute a more
permeable bilayer and we expected that such structures would effect the in vitro reconstitution
of MprF activity. Specific activity of membrane fractions was measured under the conditions
described above (section 3.1) with 0.5 mg/ml of extract in the presence of 5 μM [14C]Lys-
tRNALys, 2 mg/ml PG and a range of concentrations of Triton X100 (0−5.3 mg/ml). The mix
of PG, detergent and membrane extract was pre-incubated for 10 min at 37 °C before initiation
of the reaction by addition of the aminoacylation mix. In this first approach, the detergent was
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not removed from the reaction media before the initiation of the reaction, but diluted 1.4-fold
upon addition of the aminoacylation mix. In order to standardize the amount of detergent added
in the assay and to report the specific activity versus the ratio of Triton X-100:Lipids (w/w),
the concentration of lipids in the membrane fraction was determined (19). The lipid
concentration in the membrane fraction was 3.33 mg/ml (with 10.8 mg/ml protein) bringing
the total amount of lipid in the assay to 2.1 mg/ml. Figure 4 shows the specific activity of MprF
in the membrane fraction as a function of the ratio of Triton X100:Lipids (w/w) in the assay.
Optimal conditions for the reaction were found without Triton X-100, and a suboptimal peak
of activity was reached with a ratio of Triton X100:lipid of 0.8.
4. Future Applications
The results above show that Lys-tRNALys PG transferase activity can be quantitatively
monitored under steady-state conditions, allowing future investigation of substrate specificity
and structure-function studies of MprF proteins. The specificity of MprF for the aminoacyl-
and tRNA moieties of aminoacyl-tRNA can be studied for any substrate that can be efficiently
assembled either by an aminoacyl-tRNA synthetase or a flexizyme (20). Numerous Lys
analogues are substrates of LysRSs (21) and can be readily used to form an array of new aa-
tRNALys variants with which to investigate recognition of the aminoacyl- moiety by MprF.
Moreover, transplanting an orthologous identity set into tRNALys could also provide
tRNALys aminoacylated with non-cognate amino acids (22). tRNA recognition by MprF can
now be investigated by determining the tRNA identity set for this protein using tRNALys
variants that are substrates of LysRS. The techniques presented above can also be used to
investigate the specificity of MprF for other lipids using commercially available compounds
(cardiolipin, lipoteichoic acid) or lipid mixtures radiolabeled in vivo. Overall, the versatility of
the techniques described here will now allow for the first time a robust and systematic
investigation of the biochemical activities of the MprF superfamily, an emerging group of
bacterial virulence factors.
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Figure 1.
TLC analysis of lipids from E. coli. Lipids were extracted from E. coli C43 transformed with
pet33b (A) and from E. coli C43 expressing B. subtilis Mprf (B). TLC plates were developed
in a one dimensional (vertical) or a two dimensional solvent system (see text section 2.4). Total
lipids were revealed with iodine (I2), amino lipids with ninhydrine (N) and [32P]-radiolabelled
phospholipids by phosphorimaging (32P). PE: phosphoethanolamine, PG:
phosphatidylglycerol, CL: cardiolipin, KPG: lysyl-phosphatidylglycerol, o: TLC origin.
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Figure 2.
In vitro kinetic assays for [14C]Lys-PG synthesis. (A) TLC assay. Lower panel: [14C]Lys-PG
concentration derived from the phosphorimaging quantitation of the TLC. (B) Extraction and
scintillation counting assay (see text section 3.1). [14C]Lys-PG concentrations are represented
by circles and Lys-tRNALys concentrations by squares. Both methods (A, B) were applied
simultaneously in the presence of a membrane fraction from the E. coli C43 strain expressing
B. subtilis MprF (+MprF, filled symbols) or without expression of MprF (-MprF, open
symbols).
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Figure 3.
Specific activity of Lys-PG synthesis from membrane extracts as a function of reaction media
pre-incubation time (see text section 3.2). n=2.
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Figure 4.
Specific activity of Lys-PG synthesis from membrane extracts as a function of PG
concentration. 0.25 mg/ml membrane extract were saturated by increasing amounts of PG (see
text section 3.3). n=2.
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Figure 5.
Specific activity of Lys-PG synthesis from membrane extracts as a function of the ratio of
Triton X-100:Lipid (w/w). (see text section 3.4). No Triton X-100 was added to the reaction
media for the × axis value = 0. n=2.
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